13F HOLDINGS REPORT
Darwin Global Management, Ltd.
Quarter ended Q2 2023 · Filed May 15, 2023 · Accession 0001892688-23-000053
Total Value
$365.6M
Positions
4
Other Managers
0
Confidential Omitted
No
Holdings (4)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | TG THERAPEUTICS INC | TGTX | 10,451,241 | $157.2M | 42.99% |
| 2 | ARGENX SE | ARGX | 285,198 | $106.3M | 29.06% |
| 3 | AMBRX BIOPHARMA INC | 02290A102 | 11,304,573 | $100.8M | 27.58% |
| 4 | KEROS THERAPEUTICS INC | KROS | 31,386 | $1.3M | 0.37% |